Accelerating Growth Presented by: Brad Rogers President 1 TSX: - - PowerPoint PPT Presentation

accelerating growth
SMART_READER_LITE
LIVE PREVIEW

Accelerating Growth Presented by: Brad Rogers President 1 TSX: - - PowerPoint PPT Presentation

Accelerating Growth Presented by: Brad Rogers President 1 TSX: TRST canntrust.ca A focused medical approach to meet the specific needs of the physicians and patients Standardized products provide us the ability to label claim on


slide-1
SLIDE 1

Accelerating Growth

canntrust.ca

Presented by: Brad Rogers

President

1

TSX: TRST

slide-2
SLIDE 2

canntrust.ca

  • A focused medical approach to meet

the specific needs of the physicians and patients

2

  • Standardized products provide us the

ability to label claim on every SKU

slide-3
SLIDE 3

Wellness Global Medical Regulated Recreational Canada Companion Pets Health & Beauty Beverages

  • Low-cost scale production
  • High-quality standardized products
  • Label claim on every SKU
  • Robust distribution

Built on a solid foundation and focused on the future for our customers, shareholders and employees.

slide-4
SLIDE 4

Improving the Quality of your Life

canntrust.ca

Global Medical Market

4

slide-5
SLIDE 5

canntrust.ca

Within Canada we have a broad portfolio to meet the needs of

  • ur 50,000+ customers

5

# of Producers

  • 105 producers
  • 33 producers
  • 2 producers
  • CannTrust patented
  • 4 producers
  • CannTrust only Vegan capsule
slide-6
SLIDE 6

Multiple global joint ventures to capitalize

  • n the $180B market
  • pportunity

canntrust.ca

Denmark

  • Joint venture with

Australia

– License to produce and sell medical cannabis

Germany

– Export partnership with one of the largest pharmaceutical distributors in the country 6

Netherlands

– Export and JV partnership for local cultivation

to produce and sell medical cannabis

More partnerships in development.

slide-7
SLIDE 7

Our Global Pharmaceutical Partner

  • Partnership to develop

proprietary and novel dosage forms

  • Distribution to 115 countries

globally

  • Accessibility to global regulatory

canntrust.ca

7

slide-8
SLIDE 8

Committed to generating evidence regarding the therapeutic use and clinical effectiveness of cannabinoids. Participating in two globally leading randomized placebo controlled clinical trials.

Cannabis Oil for Chronic Non-Cancer Pain Treatment (CONCEPT) Slowing the disease progression in patients with Amyotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND).

More clinical trials being developed.

slide-9
SLIDE 9

Improving the Quality of your Life

canntrust.ca

Recreational Market

9

slide-10
SLIDE 10

A house of brands – Designed to target specific consumer segments. Distribution drives revenue - Supply agreements with 9 provinces.

10

With strains like Flix’N Chill™ carefully curated for specific occasions, Xscape takes the guesswork out of choosing which product is right for you. With our proprietary strains of popular phenotypes, liiv helps the experienced user attack their day. A cannabis collection as good as the company you keep, these flavour forward strains are perfect for any social

  • ccasion.

Inspired by the sights, smells and sounds

  • f nature. The more we connect with

nature, the more we reconnect with

  • urselves.
slide-11
SLIDE 11

Exclusive partnership to represent CannTrust’s products to Canadian adult consumers for recreational use

  • The largest Canadian beverage alcohol

broker of premium spirits, wine and beer brands

  • 100% retail coverage
  • Strong relationships with every provincial

board

  • Superior business insights, strategies,

technology and analytic tools to be a differentiator in the marketplace.

slide-12
SLIDE 12

Improving the Quality of your Life

canntrust.ca

Companion Pet Market

12

slide-13
SLIDE 13

canntrust.ca

A global, veterinary-focused leader in the companion animal health cannabis market

13

slide-14
SLIDE 14

canntrust.ca

14

In Canada alone consumers spend approximately $750 Million annually on pharmaceuticals for their beloved pets.

slide-15
SLIDE 15

Improving the Quality of your Life

canntrust.ca

Innovation

15

slide-16
SLIDE 16

16

  • Disruptive auto flower

genetics that lower capital costs and cost per gram

  • Ideal for extraction

technology for the edibles market

  • Provides for unlimited

production capacity for greenhouse and field crop both domestically and internationally

Low Tech Greenhouse/Outdoor Grow

Category Measurement

Yield

(gram per sq. ft annually)

120

Crops per Year

3

COGs ($/g)

70% reduction vs current

Lowest cost, 80% flower for extraction

slide-17
SLIDE 17

Encapsulating cannabinoids using proprietary patent-pending nanotechnology improves bioavailability, solubility in water and significantly better dispersion

  • f cannabinoids in the finished product.
slide-18
SLIDE 18

Our proprietary patent-pending nanotechnology platform will enable the development

  • f cannabis products across many consumer product categories and formats.
slide-19
SLIDE 19

2019/2020: Brewbudz™

canntrust.ca

  • U.S. and Canadian patents issued

using a single-serve brewing pods for Keurig, Nespresso and Tassimo type brewers

  • Successfully launched in U.S.

market

  • Single serve pods will be offered in

Canada when the edible market

  • pens in 2019!

19

slide-20
SLIDE 20

canntrust.ca

DATA-BASED DECISION MAKING

  • 10 PHDs ON STAFF

DOCTORS DETAILING DOCTORS EVERY EMPLOYEE IS AN OWNER

All key aspects of the business are fortified with subject matter experts

20

slide-21
SLIDE 21

Chris Lucky Peter Aceto Ilana Platt Michael Ravensdale Lea Romanelli Rob Schenkel Kaivan Talachian Bernard Yeung Jeffrey Zietlow Brad Rogers Ian Abramowitz

slide-22
SLIDE 22

22

The team brings brand building experience in Canada and internationally across CPG, alcohol and major retailers

slide-23
SLIDE 23

$180 B Wellness Global Medical Regulated Recreational Canada Companion Pets Health & Beauty $5 - $9 B $1.4 B $21 B $? B Beverages Market Size

slide-24
SLIDE 24

$6.14 $6.98 $7.84 $9.05 $- $1.00 $2.00 $3.00 $4.00 $5.00 $6.00 $7.00 $8.00 $9.00 $10.00 Q317 Q417 Q118 Q218

Revenue ($M)

667 758 982 1,063

  • 200

400 600 800 1,000 1,200 Q317 Q417 Q118 Q218

Sales (kg & kg equiv)

$8.78 $8.87 $7.63 $8.36 $7.00 $7.20 $7.40 $7.60 $7.80 $8.00 $8.20 $8.40 $8.60 $8.80 $9.00 Q317 Q417 Q118 Q218

  • Av. Sales Price per Gram

31 37 40 45 5 10 15 20 25 30 35 40 45 50 Q317 Q417 Q118 Q218

Patients (000)

slide-25
SLIDE 25

canntrust.ca

25

Accelerating Growth

TSX: TRST Contact Information: Investor@canntrust.ca Thank You

slide-26
SLIDE 26

Forward-Looking Statement

canntrust.ca Certain statements in this presentation are “forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always using words or phrases such as “expect”, “seek”, “endeavour”, “anticipate”, “plan”, “estimate”, “believe”, “intend”, or stating that certain actions, events or results may, could, would, might or will occur or be taken, or achieved) are not statements of historical fact and may be “forward-looking statements”. Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which would cause actual results or events to differ materially from those presently anticipated. Forward-looking statements are based on expectations, estimates and projections at the time the statements are made and involve significant known and unknown risks, uncertainties and assumptions. A number of factors could cause actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward- looking statements including but not limited to the risk factors set out in Appendix III of this

  • presentation. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward- looking statements prove incorrect, actual results, performance or achievements could vary materially

from those expressed or implied by the forward-looking statements contained in this document. These factors should be considered carefully and prospective investors should not place undue reliance on these forward-looking

  • statements. Although the forward-looking statements contained in this document are based upon what CannTrust currently believes to be reasonable assumptions, CannTrust cannot assure prospective investors that actual results,

performance or achievements will be consistent with these forward-looking statements. Except as required by law, CannTrust does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances.

Disclaimers

This presentation is for information only and shall not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell or issue, or subscribe for any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The information contained herein is subject to change without notice and is based on publicly available information, internally developed data and other sources. Where any opinion or belief is expressed in this presentation, it is based on the assumptions and limitations mentioned herein and is an expression of present opinion or belief only. No warranties or representations can be made as to the origin, validity, accuracy, completeness, currency or reliability of the information. CannTrust Holdings Inc. (“CannTrust”) disclaims and excludes all liability (to the extent permitted by law), for losses, claims, damages, demands, costs and expenses of whatever nature arising in any way out of or in connection with the information in this presentation, its accuracy, completeness or by reason of reliance by any person on any of it. This presentation should not be construed as legal, financial or tax advice to any individual, as each individual’s circumstances are different. Investors should consult with their own professional advisors regarding their particular circumstances. The information contained in this presentation is not directed to persons or entities resident in the United States and does not constitute an offer or solicitation by anyone in the United States or in any other jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an offer or solicitation, unless otherwise exempt from United States securities legislation.